Naloxegol: First oral peripherally acting mu opioid receptor antagonists for opioid-induced constipation

This article gives an overview of OIC, its current management and more specifically the development and approval of naloxegol, including pharmacokinetics, details of various clinical trials, adverse effects and its current status for the management of OIC.
Source: Journal of Pharmacology and Pharmacotherapeutics - Category: Drugs & Pharmacology Authors: Source Type: research